Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Insightfil is a private digital health and medical device company developing technology to improve medication adherence and care-plan execution. Its core offering combines personalized medication packaging, NFC-enabled instrumentation, and a smartphone application that detects package opening, records adherence data, and delivers reminders and contextual notifications. The company markets its solution to pharmacies, home-care and post-acute providers, assisted living and long-term care settings, and clinical-trial users seeking better adherence monitoring. Insightfil has also received U.S. SBIR funding to advance its platform and has collaborated with UMass Chan Medical School on product development and validation. Overall, the company appears to operate as a healthcare technology platform rather than a therapeutics developer, with revenue generation tied to commercial deployment of its adherence solution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Insightfil.